Reduced-intensity allogeneic transplantation for myeloma: reality bites

被引:27
|
作者
Stewart, A. Keith [1 ]
机构
[1] Mayo Clin, Rochester, MN 55905 USA
关键词
NEWLY-DIAGNOSED MYELOMA; MULTIPLE-MYELOMA; CELL TRANSPLANTATION; SURVIVAL; THALIDOMIDE; ABNORMALITIES; THERAPY; TRIAL;
D O I
10.1182/blood-2008-12-173526
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:3135 / 3136
页数:4
相关论文
共 50 条
  • [1] Reduced-intensity allogeneic haematopoietic stem cell transplantation for multiple myeloma
    Kikuchi, T.
    Mori, T.
    Kato, J.
    Yamane, A.
    Ono, Y.
    Kunimoto, H.
    Okamoto, S.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 : S264 - S264
  • [2] Reduced-intensity conditioning allogeneic stem cell transplantation for multiple myeloma
    Garcia, A
    Sureda, A
    Martino, R
    Valcarcel, D
    Brunet, S
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S200 - S200
  • [3] Sibling and unrelated reduced-intensity conditioned allogeneic transplantation for multiple myeloma
    Crawley, C
    Szydlo, R
    Lalancette, M
    Juliusson, G
    Shimoni, A
    Nagler, A
    Ruutu, T
    Ades, L
    Michallet, M
    Urbano-Ispizua, A
    Einsele, H
    Chopra, R
    Zander, A
    Greinix, H
    Cavenagh, J
    Garban, F
    Niederwiesser, D
    Gahrton, G
    Apperley, J
    [J]. BONE MARROW TRANSPLANTATION, 2003, 31 : S57 - S57
  • [4] Reduced-intensity allogeneic transplantation for lymphoma
    Kogel, KE
    McSweeney, PA
    [J]. CURRENT OPINION IN ONCOLOGY, 2002, 14 (05) : 475 - 483
  • [5] Reduced-intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma
    Majolino, I
    Arana, MG
    Riccardi, M
    Locasciulli, A
    Bacigalupo, A
    Di Bartolomeo, P
    Scimè, R
    Olivieri, A
    Narni, F
    De Fabritiis, P
    Corradini, P
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 : S37 - S38
  • [6] Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation in Myeloma: A Prospective Trial
    Gahrton, G.
    Bjoerkstrand, B.
    Iacobelli, S.
    Hegenbart, U.
    Gruber, A.
    Greinix, H.
    Volin, L.
    Narni, F.
    Musto, P.
    Beksac, M.
    Bosi, A.
    Milone, G.
    Corradini, P.
    Goldschmidt, H.
    de Witte, T.
    Morris, C.
    Niederwieser, D.
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S9 - S10
  • [7] Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma
    Taku Kikuchi
    Takehiko Mori
    Yuya Koda
    Sumiko Kohashi
    Jun Kato
    Takaaki Toyama
    Tomonori Nakazato
    Yoshinobu Aisa
    Takayuki Shimizu
    Shinichiro Okamoto
    [J]. International Journal of Hematology, 2015, 102 : 670 - 677
  • [8] Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed Multiple Myeloma
    Efebera, Yvonne A.
    Qureshi, Sofia R.
    Cole, Suzanne M.
    Saliba, Rima
    Pelosini, Matteo
    Patel, Ronak M.
    Koca, Ebru
    Mendoza, Floralyn L.
    Wang, Michael
    Shah, Jatin
    Alousi, Amin
    Hosing, Chitra
    Popat, Uday
    Kebriaei, Partow
    Anderlini, Paolo
    Khouri, Issa F.
    Champlin, Richard
    Giralt, Sergio
    Qazilbash, Muzaffar H.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (08) : 1122 - 1129
  • [9] Reduced-intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma
    Majolino, I
    Carnevalli, E
    Locasciulli, A
    Di Bartolomeo, P
    Scimè, R
    Corradini, P
    Selleri, M
    Narni, F
    Musso, M
    Bregni, M
    Olivieri, A
    De Fabritiis, P
    Pogliani, L
    Ruscio, C
    Bacigalupo, A
    [J]. BONE MARROW TRANSPLANTATION, 2006, 37 : S144 - S145
  • [10] Outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for multiple myeloma
    Kikuchi, Taku
    Mori, Takehiko
    Koda, Yuya
    Kohashi, Sumiko
    Kato, Jun
    Toyama, Takaaki
    Nakazato, Tomonori
    Aisa, Yoshinobu
    Shimizu, Takayuki
    Okamoto, Shinichiro
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 102 (06) : 670 - 677